1 |
Laurin, N., J. P. Brown, J. Morissette, and V. Raymond. 2002. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70, 1582-1588.
DOI
|
2 |
Moscat, J. and M. T. Diaz-Meco. 2002. The atypical PKC scaffold protein P62 is a novel target for anti-inflammatory and anti-cancer therapies. Adv. Enzyme Regul. 42, 173-179.
DOI
|
3 |
Rabbee, N. and T. P. Speed. 2006. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 22, 7-12.
DOI
|
4 |
Ralston, S. H. 2008. Pathogenesis of Paget's disease of bone. Bone 43, 819-825.
DOI
|
5 |
van Staa, T. P., P. Selby, H. G. Leufkens, K. Lyles, J. M. Sprafka, and C. Cooper. 2002. Incidence and natural history of Paget's disease of bone in England and Wales. J. Bone Miner Res. 17, 465-471.
DOI
|
6 |
Wooten, M. W., M. L. Seibenhener, V. Mamidipudi, M. T. Diaz-Meco, P. A. Barker, and J. Moscat. 2001. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. J. Biol. Chem. 276, 7709-7712.
DOI
|
7 |
Cho, Y. S., M. J. Go, Y. J. Kim, J. Y. Heo, J. H. Oh, H. J. Ban, D. Yoon, M. H. Lee, D. J. Kim, M. Park, S. H. Cha, J. W. Kim, B. G. Han, H. Min, Y. Ahn, M. S. Park, H. R. Han, H. Y. Jang, E. Y. Cho, J. E. Lee, N. H. Cho, C. Shin, T. Park, J. W. Park, J. K. Lee, L. Cardon, G. Clarke, M. I. McCarthy, J. Y. Lee, B. Oh, and H. L. Kim. 2009. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Genet. 41, 527-534.
DOI
|
8 |
Cody, J. D., F. R. Singer, G. D. Roodman, B. Otterund, T. B. Lewis, and M. Leppert. 1997. Genetic linkage of Paget disease of the bone to chromosome 18q. Am. J. Hum. Genet. 61, 1117-1122.
DOI
|
9 |
Cole, R. E. 2008. Improving clinical decisions for women at risk of osteoporosis: dual-femur bone mineral density testing. J. Am. Osteopath Assoc. 108, 289-295.
|
10 |
Duran, A., M. Serrano, M. Leitges, J. M. Flores, S. Picard, and J. P. Brown. 2004. The atypical PKC-interacting proein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6, 303-309.
DOI
|
11 |
Good, D. A., F. Busfield, B. H. Fletcher, P. K. Loveloc, D. L. Duffy, and J. B. Kesting. 2004. Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 35, 277-282.
DOI
|
12 |
Hocking, L. J., G. J. Lucas, A. Daroszewska, J. Mangion, M. Olavesen, T. Cundy, G. C. Nicholson, L. Ward, S. T. Bennett, W. Wuyts, W. Van Hul, and S. H. Ralston. 2002. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum. Mol. Genet. 11, 2735-2739.
DOI
|
13 |
Joung, I., J. L. Strominger, and J. Shin. 1996. Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc. Natl. Acad. Sci. USA 93, 5991-5995.
DOI
|